URGN Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

SPRZEDAż 108423 min ago

@ $19.19

Wydano: 13 vas. 2024 @ 18:02

Zwrot: -26.27%

Poprzedni sygnał: vas. 12 - 22:11

Poprzedni sygnał: Kupno

Zwrot: -0.20 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 23:00):

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases...

Stats
Dzisiejszy wolumen	135 619
Średni wolumen	364 868
Kapitalizacja rynkowa	482.83M
EPS	$0 ( 2024-03-21 )
Następna data zysków	( $-0.930 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.99
ATR14	$0.0290 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-18	Schoenberg Mark	Sell	12 000	Ordinary Shares
2024-01-31	Kim Dong	Buy	3 333	Ordinary Shares
2022-03-25	Kim Dong	Buy	20 000	Stock Option (right to buy)
2024-02-01	Smith Jason Drew	Sell	3 328	Ordinary Shares
2024-02-01	Smith Jason Drew	Sell	1 248	Ordinary Shares

INSIDER POWER
58.83
Last 96 transactions
Buy: 1 308 776 \| Sell: 407 960

Wolumen Korelacja

Długi: 0.26 (neutral)

Krótki: -0.02 (neutral)

Signal:(62.511) Neutral

Urogen Pharma Ltd Korelacja

10 Najbardziej pozytywne korelacje
SVAC	0.916
GOODM	0.907
TLGT	0.891
MTSL	0.871
NSTS	0.866
TTWO	0.86
LUNG	0.851
PAIC	0.851
RMNI	0.845
RCM	0.833

10 Najbardziej negatywne korelacje
LWAC	-0.955
SRAC	-0.919
AMRB	-0.902
LMRKN	-0.889
NETE	-0.881
KNSA	-0.847
UTHR	-0.847
RAVN	-0.84
OFS	-0.831
TECH	-0.828

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Urogen Pharma Ltd Korelacja - Waluta/Towar

0.18
( neutral )

0.13
( neutral )

0.00
( neutral )

-0.39
( neutral )

-0.17
( neutral )

0.09
( neutral )

Urogen Pharma Ltd Finanse

Annual	2023
Przychody:	$82.71M
Zysk brutto:	$73.35M (88.68 %)
EPS:	$-3.55

FY	2023
Przychody:	$82.71M
Zysk brutto:	$73.35M (88.68 %)
EPS:	$-3.55

FY	2022
Przychody:	$64.36M
Zysk brutto:	$56.70M (88.11 %)
EPS:	$-4.79

FY	2021
Przychody:	$48.04M
Zysk brutto:	$42.89M (89.27 %)
EPS:	$-4.96

Financial Reports:

No articles found.

Urogen Pharma Ltd

UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. It is also developing UGN-301 for the treatment of high-grade non-muscle invasive bladder cancer. The company has a license agreement with Allergan Pharmaceuticals International Limited for developing and commercializing pharmaceutical products that contain RTGel and clostridial toxins; Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and strategic research collaboration with MD Anderson to advance investigational treatment for high-grade bladder cancer. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.